In hepatocellular carcinoma, PRMT5-catalyzed repressive dimethylation on H4R3 at the B-cell translocation gene 2 (BTG2) promoter increases cell proliferation through the ERK signaling pathway [57]. The gene discussed is BTG2; the disease is hepatocellular carcinoma.